HAVCR2 and cancer: We may be seeing hints of that here: NK cells which upregulate TIM-3 can respond to cancer targets by assuming an altered, more “exhausted,” activation status marked by lower TIM-3 expression and a lower cytotoxicity under certain activation conditions.